Bipolar disorder is one of the most common mood disorders and is considered among the most debilitating psychological conditions. In addition to affecting performance, it significantly impacts interpersonal interactions and the overall quality of life of the patient (
1). Bipolar disorder is categorized into two types: Type I and type II, as well as cyclothymic disorder (
2). In recent years, there has been increasing attention on the diagnosis of bipolar disorder (
3). According to the World Health Organization, in 2000, bipolar disorder was ranked as the sixth leading cause of lifelong disability among individuals aged 15 to 44 years (
4). Studies suggest that the prevalence of bipolar disorder is approximately 1% (
5). Type II bipolar disorder typically begins in late adolescence or early adulthood, with an average onset age between 20 and 30 years, slightly later than type I bipolar disorder but earlier than major depressive disorder (
6).
There is limited evidence regarding gender differences in bipolar disorder, though some clinical samples suggest that type II bipolar disorder is more common in women than men, with a high risk of suicide. About one-third of individuals with type II bipolar disorder report a history of attempting suicide during their lifetime. It appears that the lifetime prevalence of suicide attempts is similar in both type I and type II bipolar disorder (32.4% and 36.3%, respectively) (
7).
Emotional intelligence is one of the key factors that plays a crucial role in the development of various psychological conditions (
8). Emotional intelligence refers to the ability, capacity, or skill to understand, assess, and manage one's own and others' emotions, encompassing the knowledge and control of emotions (
9). One critical component of emotional intelligence is emotion regulation. However, there is a lack of experimental studies providing evidence that confirms the association between emotion dysregulation and bipolar disorder (
10). Emotional dysregulation is thought to be one of the factors contributing to vulnerability to bipolar disorder. Psychological literature suggests that emotional regulation is a significant factor in determining successful performance in both health and social interactions (
11). Emotion plays a central role in all affective disorders, with emotional dysregulation being present in all Axis I disorders and half of Axis II disorders (
12).
The findings of Kraaji and Garnefski indicated that individuals with psychiatric disorders, particularly those with bipolar disorder, tend to use maladaptive emotional regulation strategies more frequently while employing adaptive strategies less often. Bipolar patients also tend to lack the reappraisal emotional regulation strategy. Moreover, preliminary studies have shown that positive reappraisal is negatively associated with psychopathological indices. According to Kraaji and Garnefski's research, there is a clear relationship between maladaptive strategies such as rumination, self-reprimand, catastrophizing, and the absence of positive reappraisal with the presence of bipolar symptoms (
13). Research has also shown that bipolar disorder negatively impacts the lives of individuals, leading to various occupational, academic, and behavioral problems (
14). Pharmacotherapy alone has proven insufficient in preventing relapse, as other factors contribute to its occurrence. Studies investigating the causes of relapse in bipolar disorder have highlighted factors such as non-adherence to pharmacotherapy, the presence of micro-symptoms, and residual mania and depression. In other words, nonpharmacological treatments are essential alongside pharmacotherapy (
15). Today, the search for effective treatment has long been a focus of psychiatrists and psychologists. The primary aim of treatment in bipolar disorder is to address the acute stage of the illness and prevent relapse. Although pharmacotherapy remains a well-established treatment for bipolar disorders, recent studies have demonstrated that adding psychosocial interventions to the treatment plan enhances its efficacy (
16).
One therapy that has recently been employed alongside pharmacotherapy for patients with bipolar disorder is mindfulness therapy. Derived from cognitive behavioral therapy, mindfulness is a key component of the third wave of psychotherapy models (
17). Mindfulness has a long history and has been an integral part of Buddhist meditation. It refers to the process of paying attention without judgment to internal and external events as they arise in the present moment. Internal events include thoughts, emotions, perceptions, and bodily sensations, while external events encompass situational and interpersonal experiences. Mindfulness involves moment-to-moment awareness of experience, characterized by intentional attention and judgment-free acceptance of one's experiences (
18).
In essence, mindfulness is a nonjudgmental, present-focused awareness of the experience at the center of one's attention in any given moment. It also includes the acceptance of recalled experiences (
19). Today, mindfulness-based interventions are used to treat a wide range of physical and psychological disorders. Research indicates that mindfulness therapy has a significant impact on mood and anxiety disorders, chronic pain (
19), post-traumatic stress disorder (
20), impulsivity (
21), addictive behaviors (
22), depression, anxiety, quality of life (
23), and reducing stress and psychological distress. Mindfulness emphasizes the interaction between cognitive, bodily, and emotional processes (
24).